The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Kite/Gilead
Stock and Other Ownership Interests - Kite/Gilead
A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.
 
Robert F. Cornell
No Relationships to Disclose
 
Frederick Lundry Locke
Honoraria - Kite/Gilead
Consulting or Advisory Role - Cellular Biomedicine Group
Research Funding - FORMA Therapeutics; Kite/Gilead
Patents, Royalties, Other Intellectual Property - Survivin Vaccine Patent
 
Michael Russell Bishop
Employment - UnitedHealthcare
Honoraria - Celgene
Consulting or Advisory Role - Seagen
Speakers' Bureau - Celgene; Juno Therapeutics; Novartis
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; BioTheryX; Bristol-Myers Squibb; Celgene; FORMA Therapeutics; Incyte; Janssen; Kite/Gilead; Legend Biotech; Pfizer; Sanofi/Aventis; Takeda
Research Funding - Amgen; BioTheryX; Bristol-Myers Squibb; Celgene; Takeda
 
Sarah Marie Larson
No Relationships to Disclose
 
Ivan Borrello
Leadership - WindMIL
Stock and Other Ownership Interests - WindMIL
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - WindMIL
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Sergio Giralt
Honoraria - Amgen; CELGENE; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Janssen; Jazz Pharmaceuticals; Sanofi; Takeda
Research Funding - Celgene (Inst); Celgene (Inst); Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Ajay K. Nooka
Consulting or Advisory Role - Novartis; Onyx
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bluebird Bio; Bristol-Myers Squibb; Celgene; Takeda
 
John M. Rossi
No Relationships to Disclose
 
Lisa Thomrongsith
Employment - Johnson & Johnson; Kite/Gilead
Stock and Other Ownership Interests - Johnson & Johnson; Kite/Gilead; Myovant Sciences
Travel, Accommodations, Expenses - Johnson & Johnson; Kite/Gilead
 
Allen Xue
Employment - Kite/Gilead
Stock and Other Ownership Interests - Amgen; Kite/Gilead
 
Zachary Roberts
Employment - Kite/Gilead
Stock and Other Ownership Interests - Kite/Gilead